SCHEMBL2567733

SCHEMBL2567733

[CH2]CCC=C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL726154 0.81
SCHEMBL2569586 0.79
SCHEMBL5439184 0.78
SCHEMBL1322409 0.77
SCHEMBL4830633 0.77
SCHEMBL4833922 0.77
SCHEMBL3564481 0.77
SCHEMBL4833880 0.77
SCHEMBL4837543 0.77
SCHEMBL4840348 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0618207-B1 Substituted pyridopyrimidines as antihypertensives AMERICAN HOME PROD (US) 1999-01-07 EP claimed
EP-0863143-A1 Intermediates useful in the production of pyridopyrimidone angiotensin AII antagonists AMERICAN HOME PRODUCTS CORPORATION (US) 1998-09-09 EP claimed
EP-0618207-A1 Substituted pyridopyrimidines as antihypertensives AMERICAN HOME PRODUCTS CORPORATION (US) 1994-10-05 EP claimed
US-11555009-B2 2-(substituted benzene matrix) aromatic formate FTO inhibitor, preparation method therefor, and applications thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2023-01-17 US disclosed
CN-108524482-B Use of 2- (substituted phenylamino) benzoic acid FTO inhibitors for treating leukemia 中国科学院上海药物研究所 2022-11-25 CN disclosed
CN-114907267-A Pharmaceutical composition for resisting tumor 中国科学院上海药物研究所 2022-08-16 CN disclosed
US-20200079727-A1 2-(SUBSTITUTED BENZENE MATRIX) AROMATIC FORMATE FTO INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2020-03-12 US disclosed
EP-3270196-B1 METHOD FOR MANUFACTURING A BANDPASS FILTER FUJIFILM CORP (JP) 2019-11-13 EP disclosed
CN-104069092-B 2- (replacing phenylamino) benzoic acid and its ester type compound prepare the purposes of FTO inhibitor 中国科学院上海药物研究所 2019-10-01 CN disclosed
CN-109310585-A External preparation for skin for improving wrinkles 宝丽化成工业有限公司 2019-02-05 CN disclosed
CN-108807180-A Method for forming semiconductor device 台湾积体电路制造股份有限公司 2018-11-13 CN disclosed
EP-0513810-A1 Peptide mimetic compounds useful as platelet aggregation inhibitors G.D. Searle & Co. (US) 1992-11-19 EP disclosed
CN-1057269-A Peptide compounds and preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1991-12-25 CN disclosed
EP-0457195-A2 Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-11-21 EP disclosed
EP-0315899-A2 Thien-3-yl azo dyes BASF Aktiengesellschaft (DE) 1989-05-17 EP disclosed
CN-85104455-A Novel tetrahydro-beta-carboline derivatives and process for preparing same 1986-12-10 CN disclosed
EP-0008540-B1 2-ARYL-1,3-INDANDIONE DERIVATIVES AND COMPOSITIONS COMPRISING THEM FOR CONTROLLING ECTOPARASITIC ACARINA UNION CARBIDE CORPORATION (US) 1984-10-24 EP disclosed
US-4394520-A SKIN DISORDERS SOCIETE ANONYME DITE: L'OREAL (FR) 1983-07-19 US disclosed
US-4204064-A FOR TREATMENT OF SKIN OR SCALP L'OREAL (FR) 1980-05-20 US disclosed
US-4085217-A DERIVATIVES OF CYSTEINE OR CYSTEAMINE L'OREAL (FR) 1978-04-18 US disclosed